System and Method for Wireless Communication of Analyte Data Keeping a Glucose Sensor Reliably Connected to the Phone in Your Pocket

This patent covers the wireless plumbing behind a continuous glucose monitor: how a body-worn sensor is calibrated and tested in the factory, and how it then sends glucose readings, connection information and alarms to a phone or dedicated display. It comes from Dexcom, Inc., the American company behind the widely used G6 and G7 glucose sensors.

The Problem

Diabetes is a condition in which the body either cannot produce enough insulin or cannot use it effectively, and the resulting swings in blood sugar cause serious long-term damage to blood vessels, kidneys, eyes and nerves. For decades the standard tool was a fingerprick meter. Because pricking a finger hurts and is inconvenient, most people only tested two to four times a day, which left long blind gaps. A single number also says nothing about direction: it cannot tell you whether glucose is climbing towards a dangerous high or falling towards a hypoglycaemic low.

Continuous sensors solved the sampling problem by measuring under the skin around the clock, but they created a new one. The sensor is a tiny, battery-limited device that has to hand its data to a phone, a receiver or an insulin pump over a radio link that will inevitably drop out. If the connection silently fails, an alarm that should have woken someone at 3am never arrives. The sensors also have to be individually calibrated and tested during manufacture, at volumes of millions of units, which needs its own automated wireless infrastructure.

What This Invention Does

The application describes a family of related systems that together cover the full life of a continuous analyte sensor’s wireless link. At the factory end it sets out a calibration station and a testing system that communicate with the sensor electronics wirelessly, so units can be calibrated and verified without physical connectors. At the user end it describes the sensor system, the display device and peripheral devices, and the way they exchange three distinct kinds of information: the analyte data itself, connection status data, and alarm or alert data.

Treating connection state as first-class data is the heart of it. Rather than assuming the radio link works, the devices explicitly track and communicate whether they are paired and in range, so a break in Bluetooth Low Energy coverage can be surfaced to the wearer instead of being mistaken for stable glucose. The same framework lets alarms be routed to whichever device is currently reachable, and lets peripheral devices such as a watch or a pump participate in the same conversation.

Key Features

• Wireless calibration station. A station calibrates a continuous analyte sensor system over a radio link rather than a wired connection.
• Automated testing systems. Matching methods and systems test a finished sensor system wirelessly during manufacture.
• Analyte data transmission. The sensor system, display device and peripherals are configured to exchange continuous glucose readings.
• Connection state as data. Connection information is communicated explicitly, so dropouts are detected and reported rather than passing unnoticed.
• Alarm and alert routing. Alarms and alerts are treated as their own data class and delivered to reachable devices.
• Peripheral device support. Watches, receivers, pumps and similar peripherals can join the same wireless system.

Who Is Behind It

The applicant is Dexcom, Inc. of San Diego, California, one of the two dominant makers of continuous glucose monitoring hardware worldwide. The application names fourteen inventors, including Robert Patrick Van Tassel, John Francis Loughlin, Sean S. Nihalani, James Stephen Amidei, Stephen Alan Reichert, Sebastian Bohm, Krishna Prashant Daita, Brian Christopher Smith, Michael A. Ploof, Benjamin Elrod West, Mark S. Dervaes, Vincent P. Crabtree, William A. Pender and Douglas William Burnette. The filing is a divisional of Australian application 2020284312, which entered Australia through PCT application PCT/US2020/034275 and traces back to a United States provisional filed in May 2019.

Why It Matters

Around 1.3 million Australians live with diabetes, and continuous glucose monitoring has moved from a specialist device to a mainstream one, particularly since subsidised access widened for people with type 1 diabetes. For those users the wireless link is not a convenience feature: it is the path by which a low-glucose alarm reaches them overnight. Patents in this area are less about the biochemistry of the sensor and more about the unglamorous engineering that makes a body-worn medical device behave dependably alongside consumer phones. Protecting that work in Australia matters to Dexcom because Australia is a significant market for these systems and a place where the devices increasingly connect to automated insulin delivery pumps.

Related Concepts

• Continuous glucose monitor – the device class this invention makes more reliable.
• Bluetooth Low Energy – the short-range radio standard typically carrying this data.
• Diabetes management – the clinical practice the data feeds into.
• Artificial pancreas – closed-loop systems that depend on trustworthy sensor telemetry.
• Calibration – the factory process the wireless calibration station performs.
• Biosensor – the underlying sensing technology measuring glucose under the skin.

---

AU 2026202024 was published in the Australian Official Journal of Patents on 2 April 2026 and is open for public inspection. Patent applications represent inventions that are sought to be protected and do not necessarily reflect commercially available products.